{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-017145","form_type":"8-K/A","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.115676+00:00","generated_at":"2026-05-15T05:35:07.525725+00:00","sec_items":["1.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aspire Biopharma closes second tranche of $21M preferred offering; funds Dura Driver acquisition","bullets":["Closed second tranche of Series A Convertible Preferred stock on April 15, 2026 for 12,500 shares and gross proceeds of ~$10M.","Combined with first tranche (13,750 shares, $11M), total offering raises $21M before fees.","Amended Certificate of Designation to increase authorized Series A shares from 25,000 to 30,000.","Net proceeds to fund cash portion of proposed Dura Driver Control Systems acquisition and for general corporate purposes.","RBW Capital Partners acting through Dawson James Securities acted as placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-017145","json":"https://secwatch.observer/filing/0001493152-26-017145.json","markdown":"https://secwatch.observer/filing/0001493152-26-017145.md","text":"https://secwatch.observer/filing/0001493152-26-017145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/0001493152-26-017145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:35:07.525725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb21d196747f2ee5b372071712bf5b618fbdcc16","claim":"Aspire Biopharma Holdings, Inc.: On April 13, 2026, the Company filed a Certificate of Amendment to the Certificate of Designation of Series A Convertible Preferred Stock, amending provisions including the designation and number of shares, designating 30,000 shares with a par value of $0.0001 and a stated value of $1,000 per share (effective 2026-04-13).","evidence_excerpt":"On April 13, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Certificate of Designation of Series A Convertible Preferred Stock (the “ Certificate of Amendment ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/0001493152-26-017145-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-04-13"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}